ARTICLE | Company News
Investment firm Ares Life Sciences agreed to take allergy company Stallergenes Greer private. Ares Life Sciences (Geneva, Switzerland) will pay Stallergenes Greer plc (Euronext:STLLF) €37 ($41.85) in cash per share to acquire the 16% of shares that Ares does not already own.
The price is a 41% premium to Stallergenes' closing price of €29.62 on March 20, the day before the offer was announced, and values the company at €730 million ($825.7 million)...